You are here
Conference on Nausea and Vomiting: management of nausea and vomiting – the European vision
by Fausto Roila, recorded at TAO (Transatlantic Oncology meeting), Nov 20-21, 2014, Paris
The emetic risk of chemotherapy regimens can be classified as minimal, low, moderate or high. Fausto Roila reviews the study results of various antiemetics, including dosing, adverse events and cost-effectiveness. He discusses the beneficial effects of adding NK1 receptor antagonists.
Fausto Roila, Ospedale S. Maria di Terni, Italy